What's happening to Buffett's Tech investment, IBM?! Check out our Report to see our take on its valuation! HIDE

GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
45.36 +0.95  +2.14% NYSE Oct 23, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Enterprise Value:

134.12B for None

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Oct. 23, 2014 134.12B
Oct. 22, 2014 131.84B
Oct. 21, 2014 129.96B
Oct. 20, 2014 129.92B
Oct. 17, 2014 130.06B
Oct. 16, 2014 128.16B
Oct. 15, 2014 128.76B
Oct. 14, 2014 130.08B
Oct. 13, 2014 130.44B
Oct. 10, 2014 131.14B
Oct. 9, 2014 132.80B
Oct. 8, 2014 135.10B
Oct. 7, 2014 133.85B
Oct. 6, 2014 135.32B
Oct. 3, 2014 135.03B
Oct. 2, 2014 134.77B
Oct. 1, 2014 135.42B
Sept. 30, 2014 135.58B
Sept. 29, 2014 136.97B
Sept. 26, 2014 137.69B
Sept. 25, 2014 137.91B
Sept. 24, 2014 138.75B
Sept. 23, 2014 137.81B
Sept. 22, 2014 139.45B
Sept. 19, 2014 139.59B
Sept. 18, 2014 139.38B
Sept. 17, 2014 138.92B
Sept. 16, 2014 139.40B
Sept. 15, 2014 138.63B
Sept. 12, 2014 138.82B
Sept. 11, 2014 138.51B
Sept. 10, 2014 139.35B
Sept. 9, 2014 137.84B
Sept. 8, 2014 138.15B
Sept. 5, 2014 140.89B
Sept. 4, 2014 141.54B
Sept. 3, 2014 142.57B
Sept. 2, 2014 141.78B
Aug. 29, 2014 143.72B
Aug. 28, 2014 143.17B
Aug. 27, 2014 142.69B
Aug. 26, 2014 141.71B
Aug. 25, 2014 141.39B
Aug. 22, 2014 140.31B
Aug. 21, 2014 140.36B
Aug. 20, 2014 140.62B
Aug. 19, 2014 139.52B
Aug. 18, 2014 139.78B
Aug. 15, 2014 138.37B
Aug. 14, 2014 138.73B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for

GSK Enterprise Value Benchmarks

AstraZeneca 91.89B
Pfizer 185.48B
Johnson & Johnson 274.94B

GSK Enterprise Value Range, Past 5 Years

Minimum 98.62B May 26 2010
Maximum 160.95B Apr 29 2014
Average 131.85B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.